Professor William Gallagher:

On HPV vaccination, I do not think we have the specific expertise in this group to address the question. More generally, and again Professor Lawler would have a lot of experience at a European level in terms of equity of access to treatments and diagnostics, it is a big research question. There are significant disparities regionally across Europe and obviously there may be regional disparities within countries. In Ireland, within the national cancer control programme, there is a big focus on evening out the disparity or potential disparity that may exist.